Bill of Health

JANUARY 6, 2022

The National Institutes of Health (NIH) is currently embroiled in a dispute over the ownership of patent rights to Moderna’s flagship mRNA COVID-19 vaccine (mRNA-1273). If so, NIH, their employer, would be a co-owner of the vaccine technology and could, in theory, make it more broadly available around the world.

COVID-19 Vaccine 345

COVID-19 Vaccine COVID-19 Licensing Public Health 345

SQA

JUNE 10, 2021

Backgrounder – Government of Canada Investments in Biomanufacturing, Development of COVID-19 Vaccines and Therapeutics, and Research, 18 May 2021. That’s why the government is implementing a multi-faceted procurement strategy to provide a COVID-19 vaccine to every Canadian who wants one by September.

FDA 52

FDA COVID-19 COVID-19 Vaccine Compliance 52

Hall Render

JULY 22, 2022

Board suspends nurse’s license 17 months after arrest in stabbing incident. COVID-19 cases rise as new subvariant worries hospital officials. CDC scrambles to provide tests and vaccines. Another COVID-19 vaccine, developed by Maryland-based Novavax, approved for U.S. Iowa physicians sell $16.4M

COVID-19 40

COVID-19 Nursing Homes Nurses Hospitals 40

Drug & Device Law

DECEMBER 29, 2023

Equally bad, Hrymoc effectively read a New Jersey statute, §2A:58C-5(c), which precludes punitive damages where a “device” was “licensed” by the FDA, out of existence. The G/N MDL was created in 2013 and mostly settled in 2016. That makes Hrymoc a one-off exception from a general exclusion of §510(k) evidence. 3d , 2023 WL 5807340 (D.

FDA 105

FDA US Department of Health and Human Services COVID-19 COVID-19 Vaccine 105